Caroline Nervil Kistorp

Medicine & Life Sciences

1. Heart Failure 100%
2. empagliflozin 65%
3. Brain Natriuretic Peptide 52%
4. Type 2 Diabetes Mellitus 44%
5. Placebos 36%
6. Liraglutide 36%
7. Systolic Heart Failure 34%
8. Testosterone Congeners 30%
9. Randomized Controlled Trials 29%
10. Natriuretic Peptides 28%
11. Outpatients 24%
12. Cardiovascular Diseases 21%
13. copeptins 21%
14. pro-brain natriuretic peptide (1-76) 20%
15. Polycystic Ovary Syndrome 20%
16. Atrial Natriuretic Factor 18%
17. Stroke Volume 17%
18. Mineralocorticoid Receptor Antagonists 17%
19. Eplerenone 15%
20. Body Composition 15%
21. Mortality 15%
22. Adrenomedullin 15%
23. Biomarkers 15%
24. Sodium-Glucose Transport Proteins 14%
25. Fats 13%
26. Testosterone 12%
27. Population 12%
28. Left Ventricular Function 12%
29. Confidence Intervals 12%
30. Androgens 11%
31. MDV 3100 11%
32. Cachexia 11%
33. Elderly 10%
34. Therapeutics 10%
35. Glomerular Filtration Rate 10%
36. Abiraterone Acetate 10%
37. Hyperprolactinemia 9%
38. Photon Absorptiometry 9%
39. Prostatic Neoplasms 9%
40. Hemodynamics 9%
41. Diabetes Mellitus 9%
42. Exercise 9%
43. Castration 9%
44. Hyperthyroidism 9%
45. Inflammation 9%
46. Intra-Abdominal Fat 9%
47. Glucose 9%
48. Insulin Resistance 8%
49. Insulin-Like Growth Factor I 8%
50. Serum 8%